Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period

Journal of Dairy Science

Volumn 86, Issue 1, 2003, Pages 159-168

  Dingwell, R T ^a   Leslie, K E ^a   Duffield, T F ^a   Schukken, Y H ^b   DesCoteaux, L ^c   Keefe, G P ^d   Kelton, D F ^a   Lissemore, K D ^a   Shewfelt, W ^e   Dick, P ^f   Bagg, R ^f  

^a UNIVERSITY OF GUELPH   (Canada)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^e Tavistock Veterinarians   (Canada)

^f ELI LILLY AND COMPANY   (United States)

Author keywords

Dry cow therapy; Staphylococcus aureus; Tilmicosin

Indexed keywords

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ANTIINFECTIVE AGENT; BENZATHINE CLOXACILLIN; CLOXACILLIN; DRUG DERIVATIVE; MACROLIDE; TILMICOSIN; TYLOSIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL COUNT; CATTLE; CATTLE DISEASE; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; LACTATION; MICROBIOLOGY; MILK; PARITY; RANDOMIZATION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL MODEL; TREATMENT OUTCOME; UDDER;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CLOXACILLIN; COLONY COUNT, MICROBIAL; FEMALE; LACTATION; LOGISTIC MODELS; MACROLIDES; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; PARITY; RANDOM ALLOCATION; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; TYLOSIN;

EID: 0037645314     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(03)73596-6     Document Type: Article

References (30)

1. Barkema, H. W., D. T. Galligan, Y. H. Schukken, T. J. G. M. Lam, M. L. Beiboer, and A. Brand. 1997. Estimation of interdepenence among quarters of the bovine udder with subclinical mastitis and implications for analysis. J. Dairy Sci. 80:1592-1599.
2. Browning, J. W., G. A. Mein, M. Barton, T. J. Nicholls, and P. Brightling. 1990. Effect of antibiotic therapy at drying-off on mastitis in the dry period and early lactation. Aust. Vet. J. 67:440-442.
3. Cummins, K. A., and T. A. McCaskey. 1987. Multiple infusions of cloxacillin for treatment of mastitis during the dry period. J. Dairy Sci. 70:2658-2665.
4. Eberhart, R. J. 1986. Management of dry cows to reduce mastitis. J. Dairy Sci. 69:1721-1732.
5. Erskine, R. J., P. C. Bartlett, P. C. Crawshaw, and D. M. Gombas. 1994. Efficacy of intramuscular oxytetracycline as a dry cow treatment for Staphylococcus aureus mastitis. J. Dairy Sci. 77:3347-3353.
6. Erskine, R. J., P. C. Bartlett, S. R. Tavernier, L. H. Fowler, R. D. Walker, J. H. Sequin, and D. Shuster. 1998. Recombinant bovine interleukin-2 and dry cow therapy: Efficacy to cure and prevent intramammary infections, safety, and effect on gestation. J. Dairy Sci. 81:107-115.
7. Hensen, S. M., M. J. A. M. P. Pavičić, J. A. C. M. Lohuis, J. A. M. de Hoog, and B. Poutrel. 2000. Location of Staphylococcus aureus within the experimentally infected bovine udder and the expression of capsular polysaccharide type 5 in situ. J. Dairy Sci. 83:1966-1975.
8. Hogan, J. S., K. L. Smith, D. A. Todhunter, and P. S. Schoenberger. 1995. Efficacy of recombinant bovine interleukin-2 as an adjunct to dry cow therapy. J. Dairy Sci. 78:1062-1067.
9. Keefe, T. J. 1980. Benzathine cloxacillin as a dry-cow mastitis product. Modern Vet. Practice. September: 783-785.
10. Lam, T. J. G. M., Y. H. Schukken, J. H. van Vliet, F. J. Grommers, M. J. M. Tielen, and A. Brand. 1997. Effect of natural infection with minor pathogens on susceptibility to natural infection with major pathogens in the bovine mammary gland. Am. J. Vet. Res. 58:17-22.
11. Liang, K.-Y., and S. Zeger. 1986. Longitudinal data analysis suing generalized linear models. Biometrika 73:13-22.
12. National Mastitis Council. 1999. Pages 1-11 and 31-39 in Laboratory Handbook on Bovine Mastitis. rev. ed. Natl. Mastitis Counc., Inc., Madison, WI.
13. Natzke, R. P. 1981. Elements of mastitis control. J. Dairy Sci. 64:1431-1432.
14. Newbould, F. H. S. 1974. Antibiotic treatment of experimental Staphylococcus aureus infections of the bovine mammary gland. Can. J. Comp. Med. 38:411-416.
15. Nickerson, S. C., and C. W. Heald. 1981. Histopathologic response of the bovine mammary gland to experimentally induced Staphylococcus aureus infection. Am. J. Vet. Res. 42:1351-1355.
16. Nickerson, S. C., and R. L. Boddie. 1994. Effect of naturally occurring coagulase-negative staphylococcal infections on experimental challenge with major mastitis pathogens. J. Dairy Sci. 77:2526-2536.
17. Nickerson, S. C., W. E. Owens, L. K. Fox, C. C. Scheifinger, T. R. Shryock and T. E. Spike. 1999. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off. J. Dairy Sci. 82:696-703.
18. Østeras, O., L. Sandvik, J. Aursjo, G. G. Gjul and A. Jorstad. 1994. Effect of dry cow therapy on subclinical mastitis - an evaluation of long-acting and short acting injectors. J. Vet. Med. B.41:529-540.
19. Østeras, O., V. L. Edge, and S. W. Martin. 1999. Determinants of success or failure in the elimination of major mastitis pathogens in selective dry cow therapy. J. Dairy Sci. 82:1221-1231.
20. Rainard, P., and Bernard Poutrel. 1988. Effect of naturally occurring intramammary infections by minor pathogens on new infections by major pathogens in cattle. Am. J. Vet. Res. 49:327-329.
21. SAS User's Guide: Statistics, Release 8.01. 1999-2000. SAS Inst. Inc., Cary, N.C.
22. Scorneaux, B., and T. R. Shryock. 1999. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. J. Dairy Sci. 82:1202-1212.
23. Schukken, Y. H., K. E. Leslie, D. A. Barnum, B. A. Mallard, J. H. Lumsden, P. C. Dick, G. H. Vessie, and M. E. Kehrli. 1999. Experimental Staphylococcus aureus intramammary challenge in late lactation dairy cows: quarter and cow effects determining the probability of infection. J. Dairy Sci. 82:1-9.
24. Schukken, Y. H., L. Tikovsky, D. Wilson, and O. Østerås. 2001. Factors affecting the success of antibiotic treatment at dry-off. Pages 80-87 in Natl. Mastitis Counc. Reg. Mtg. Proc., Reno, Nevada. Natl. Mastitis Counc., Inc., Madison, Wisconsin.
25. Sears, P. M., B. S. Smith, P. B. English, P. S. Herer, and R. N. Gonzalez. 1990. Shedding pattern of Staphylococcus aureus from bovine intramammary infections. J. Dairy Sci. 73:2785-2789.
26. Smith, K. L., D. A. Todhunter, and P. S. Schoenberger. 1985. Environmental pathogens and intramammary infection during the dry period. J. Dairy Sci. 68:402-417.
27. Soback, S., G. Ziv, M. Winkler and A. Saran. 1990. Systemic dry cow therapy - a preliminary report. J. Dairy Sci. 73:661-666.
28. Sol, J., O. C. Sampimon, J. J. Snoep, and Y. H. Schukken. 1994. Factors associated with bacteriological cure after dry cow treatment of subclinical Staphylococcal mastitis with antibiotics. J. Dairy Sci. 77:75-79.
29. Ziv, G., M. Storper, and A. Saran. 1981. Comparative efficacy of three antibiotic products for the treatment and prevention of subclinical mastitis during the dry period. Vet. Q. 3:74-79.
30. Zadoks, R., Y. H. Schukken, and H. Barkema. 2000. Staphylococcus aureus: Fingerprinting the culprit. Pages 79-93 in Natl. Mastitis Counc. Reg. Mtg. Proc., Atlanta, Georgia. Natl. Mastitis Counc., Inc., Madison, WI.